Zobrazeno 1 - 10
of 115
pro vyhledávání: '"Luiza SPIRU"'
Advancing user-centric design and technology adoption for aging populations: a multifaceted approach
Publikováno v:
Frontiers in Public Health, Vol 12 (2024)
The global demographic shift toward an aging population necessitates a nuanced approach to developing and adopting assistive technologies tailored for older adults. This paper synthesizes key challenges, strategies, and recommendations identified in
Externí odkaz:
https://doaj.org/article/c17950aee5e04cfe94d82b912298a548
Autor:
Bruno Dubois, Jesús López-Arrieta, Stanley Lipschitz, Triantafyllos Doskas, Luiza Spiru, Svitlana Moroz, Olena Venger, Patrick Vermersch, Alain Moussy, Colin D. Mansfield, Olivier Hermine, Magda Tsolaki, for the AB09004 Study Group Investigators
Publikováno v:
Alzheimer’s Research & Therapy, Vol 15, Iss 1, Pp 1-10 (2023)
Abstract Background Masitinib is an orally administered tyrosine kinase inhibitor that targets activated cells of the neuroimmune system (mast cells and microglia). Study AB09004 evaluated masitinib as an adjunct to cholinesterase inhibitor and/or me
Externí odkaz:
https://doaj.org/article/83c798131c8243d0a378ebbc75a7c528
Publikováno v:
SEA: Practical Application of Science, Vol X, Iss 28 (1/2022), Pp 57-61 (2022)
Monitoring aging workers' health is important not only to prevent illness or work injury but to improve their quality of working life. In this article, we contribute to a deep understanding of the Romanian older adult workers as user experience while
Externí odkaz:
https://doaj.org/article/74f294eb5e9545a9bdc11c96b3476d31
Autor:
Bruno Dubois, Jesús López‑Arrieta, Stanley Lipschitz, Triantafyllos Doskas, Luiza Spiru, Svitlana Moroz, Olena Venger, Patrick Vermersch, Alain Moussy, Colin D. Mansfield, Olivier Hermine, Magda Tsolaki, for the AB09004 Study Group Investigators
Publikováno v:
Alzheimer’s Research & Therapy, Vol 15, Iss 1, Pp 1-1 (2023)
Externí odkaz:
https://doaj.org/article/8a299e1b5fb94a1cbdfb460cdf520c8f
Autor:
Amalia Teodora Vancea, Luiza Spiru
Publikováno v:
Ovidius University Annals: Economic Sciences Series, Vol XX, Iss 2, Pp 555-558 (2020)
The medical research conducted during the COVID-19 pandemic has highlighted numerous sequelae and readmissions (to hospitals) of patients with moderate and severe forms of COVID-19 and has outlined the need for a post-COVID 19 rehabilitation process
Externí odkaz:
https://doaj.org/article/5fafc1f388044c00b24b1c41e8cd9764
Autor:
Bogdan Ovidiu Popescu, Maria Dobre, Luiza Spiru, Catalina Tudose, Ioana Cracana, Catalina Anca Cucos, Gabriela Niculescu, Gina Manda, Elena Milanesi
Publikováno v:
F1000Research, Vol 11 (2022)
Introduction: Cognitive decline, correlating with hippocampal atrophy, characterizes several neurodegenerative disorders having a background of low-level chronic inflammation and oxidative stress. Methods: In this cross-sectional study, we examined h
Externí odkaz:
https://doaj.org/article/8dd01394953d4705b8a5c68d5d3cbe40
Autor:
Bogdan Ovidiu Popescu, Maria Dobre, Luiza Spiru, Catalina Tudose, Ioana Cracana, Catalina Anca Cucos, Gabriela Niculescu, Gina Manda, Elena Milanesi
Publikováno v:
F1000Research, Vol 11 (2022)
Introduction: Cognitive decline, correlating with hippocampal atrophy, characterizes several neurodegenerative disorders having a background of low-level chronic inflammation and oxidative stress. Methods: In this cross-sectional study, we examined h
Externí odkaz:
https://doaj.org/article/28f1aa4e3dbf43b18874dd664beeff47
Autor:
Roxana Silvia Bumbacea, Selda Ali, Sabina Loredana Corcea, Luiza Spiru, Cornelia Nitipir, Victor Strambu, Dragos Bumbacea
Publikováno v:
Clinical and Translational Allergy, Vol 11, Iss 10, Pp n/a-n/a (2021)
Abstract Background Hypersensitivity reactions induced by chemotherapeutic drugs may influence the course of the oncologic disease by preventing doctors from prescribing first‐line therapy. In order to prevent another hypersensitivity reaction to t
Externí odkaz:
https://doaj.org/article/f59ecd67bbbc48188e3cf6755a8a3bf5
Publikováno v:
Medicina, Vol 58, Iss 4, p 511 (2022)
Dabrafenib and trametinib are two available molecules that have been approved for the treatment of metastatic melanoma with BRAF-V600E or V600K mutations. Their combined therapy has led to long-lasting survival benefits and substantially improved out
Externí odkaz:
https://doaj.org/article/a2b08b195dad48d6ab2623dffe6d30cd
Autor:
Stara, Magdalen Velciu, Luiza Spiru, Mircea Dan Marzan, Eva Reithner, Simona Geli, Barbara Borgogni, Oana Cramariuc, Irina G. Mocanu, Jerzy Kołakowski, Jaouhar Ayadi, Margherita Rampioni, Vera
Publikováno v:
Sustainability; Volume 15; Issue 13; Pages: 10330
The worldwide population is undergoing a fundamental change in its age structure, which challenges the health- and social-services system. The need to migrate towards a more person-centered and coordinated model of care that supports the optimization